In the pandemic’s latest phase, strategic issues for healthcare providers include labor, inflation and value-based payment
The struggles of smaller providers amid the COVID-19 pandemic are likely to give way to increased merger-and-acquisition activity in 2022, according to Wall Street analysts.
Big delays could be in store for early No Surprises Act arbitration cases
The portal for payment arbitration cases taking place under the No Surprises Act is open for business but could be facing a backlog of cases.
Latest financial metrics for hospitals show reasons for optimism but also persistent challenges
Hospital financial performance partially recovered in March as patient volumes returned to something closer to normal after a significant downturn during the omicron wave.
M&A update: A quiet quarter for hospital deal-making reflects the ongoing consequences of the pandemic
Merger-and-acquisition activity among hospitals and health systems remained well under pre-pandemic levels in Q1 2022.
Tentative deal to provide pandemic funding won’t replenish the COVID-19 Uninsured Program
A bipartisan Senate bill would pay for additional vaccines and therapeutics but wouldn’t restore funding to a program that reimburses providers for furnishing COVID-19-related services to the uninsured.
News Briefs: Biden administration will apply closer scrutiny to healthcare billing practices
A monthly roundup of top news for healthcare finance professionals.
Medicare’s proposed increase for inpatient payments in FY23 doesn’t meet hospitals’ expectations
The hospital industry expressed disappointment with the proposed increase for inpatient payments in FY23.
CMS leaders explain final plans to restrict Medicare coverage of new Alzheimer’s drug
CMS mostly finalized previously proposed criteria for coverage of Aduhelm, which has been promoted as the first drug to treat the underlying pathology of Alzheimer’s disease.
More than 2 years into the pandemic, the issue of deferred care continues to affect the healthcare industry
Concerns about the implications of deferred care continue to grow as healthcare organizations establish their strategies for a post-pandemic landscape.
Staff, patients, benchmarks have the attention of rev cycle leaders
5 takeaways from HFMA’s Revenue Cycle Conference